METOPROLOL TARTRATE | A200981 | RUBICON RESEARCH LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Hyman, Phelps & McNamara P.C. FDA-2021-P-0124 · 8 docket documents On January 25, 2021, Hyman, Phelps & McNamara P.C. filed a suitability petition under Section 505(j)(2)(C) of the Federal Food, Drug and Cosmetic Act requesting that the FDA declare Metoprolol Tartrate Tablets, 12.5 mg, suitable for submission as an abbreviated new drug application (ANDA), with the | Suitability | 2021-01-28 | Withdrawn | Hyman, Phelps & McNamara P.C. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1421
per ea
Lowest NADAC/Unit
$0.0170
per ea
Brand NDCs
0
Generic NDCs
32
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72888002301METOPROLOL TARTRATE 75 MG TAB | $0.1421 | EA | Generic | — | 2026-06-17 |
| 52817035910METOPROLOL TARTRATE 75 MG TAB | $0.1421 | EA | Generic | — | 2026-06-17 |
| 52817035810METOPROLOL TARTRATE 37.5 MG TB | $0.0756 | EA | Generic | — | 2026-06-17 |
| 72888010101METOPROLOL TARTRATE 37.5 MG TB | $0.0756 | EA | Generic | — | 2026-06-17 |
| 52817036210METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
| 72888000600METOPROLOL TARTRATE 100 MG TAB | $0.0282 | EA | Generic | — | 2026-06-17 |
Showing 6 of 32 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.